Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000950170-25-083163

Options or other derivatives

  • Director acquired 28,480 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Radhakrishnan Maha Director 2025-06-04 Grant or award · Stock Option (Right to Buy) +28,480 28,480 D: show line 1 in the form
Loading xslF345X05/ownership.xml…